New Vernon Capital Holdings Ii LLC Amgen Inc Transaction History

New Vernon Capital Holdings Ii LLC

  • $186 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 13, 2019
SELL
$180.87 - $203.88 $245,983 - $277,276
-1,360 Closed
0 $0
Q3 2018

Nov 13, 2018
BUY
$185.29 - $208.89 $22,234 - $25,066
120 Added 9.68%
1,360 $282,000
Q2 2018

Aug 14, 2018
BUY
$166.05 - $186.51 $205,902 - $231,272
1,240 New
1,240 $229,000

Others Institutions Holding AMGN

# of Institutions
3,125
Shares Held
409M
Call Options Held
7.56M
Put Options Held
7.2M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track New Vernon Capital Holdings Ii LLC Portfolio

Follow New Vernon Capital Holdings Ii LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Vernon Capital Holdings Ii LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Vernon Capital Holdings Ii LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email